跳至主要内容
临床试验/NCT01430520
NCT01430520已完成4 期

Analgesic Effect of Perioperative Escitalopram for Patients With High Preoperative Level of Pain Catastrophising in Total Knee Arthroplasty

Hvidovre University Hospital3 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2011年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
120
试验地点
3
主要终点
Pain

研究概览

简要总结

Pain is a major problem after TKA, especially in patients with high pain catastrophizing. Newer MR-scan studies indicate that Escitalopram may have an immediate cognitive and emotional effect. The investigators therefore investigate the effect of Escitalopram as a perioperative analgesic.

详细描述

Pain is a major problem after TKA, especially in patients with high pain catastrophizing. Newer MR-scan studies indicate that Escitalopram may have an immediate cognitive and emotional effect. Patients with high pain catastrophizing are mentally vulnerable and may be sensitive to the effects of Escitalopram.

We therefore investigate the effect of Escitalopram as a perioperative analgesic in this group of patients where the pain problem is pronounced.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary, unilateral total knee arthroplasty (TKA)
  • Age > 18 > 81
  • Ethnic Danes
  • Score > 20 on Pain Catastrophising Scale

排除标准

  • Medication that causes risk in combination with SSRI (6 month)
  • Treatment for anxiety or depression
  • History of depression or mania
  • Treatment with systemic glucocorticoids (6 month)
  • Treatment with opioids (4 weeks)
  • Alcohol or drug abuse
  • History of malignancy
  • Fertile woman
  • History of epilepsia
  • Treatment with anticoagulants
  • BMI > 40
  • Disease affecting central or peripheral nerve function
  • History of gastrointestinal bleeding
  • History of hepato- or renal insufficiency
  • Allergy to Escitalopram

研究组 & 干预措施

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

Escitalopram

Active Comparator

干预措施: Escitalopram (Drug)

结局指标

主要结局

Pain

时间窗: At 24 hour

Pain during walking at 24 hour after surgery

次要结局

  • Pain(1 week)
  • Cumulated pain scores(1 week)
  • Amount of rescue analgesic(1 week)
  • Side effects(1 week)
  • Escitalopram level in blood-sample(48 hours)
  • anxiety, depression, and sleep quality(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Troels Haxholdt Lunn

MD, PHD

Hvidovre University Hospital

研究点 (3)

Loading locations...

相似试验